OTC: ARSUF - Fagron NV

Rentabilidade por seis meses: -3.93%
Rendimento de dividendos: 0.00%

Cronograma de promoção Fagron NV


Sobre a empresa Fagron NV

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.

mais detalhes
Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.55
Дивиденд ао 0.2471
Сайт https://www.fagron.com
Цена ао 20.03
Alteração de preço por dia: 0% (20.03)
Alteração de preço por semana: 0% (20.03)
Alteração de preço por mês: 0% (20.03)
Alteração de preço em 3 meses: 0% (20.03)
Mudança de preço em seis meses: -3.93% (20.85)
Mudança de preço por ano: +7.75% (18.589)
Mudança de preço desde o início do ano: 0% (20.03)

Subestimação

Nome Significado Nota
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Eficiência

Nome Significado Nota
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0.7143 7.14
Total: 3.94

Obrigação

Nome Significado Nota
Debt/EBITDA 0 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 56.52 7
Rentabilidade Ebitda, % 0 0
Rentabilidade EPS, % 22.08 4
Total: 5.4

Supervisor Cargo Pagamento Ano de nascimento
Mr. Rafael Padilla CEO & Executive Director 1.2M 1978 (47 anos)
Ms. Karin de Jong CFO & Executive Director 710.81k 1979 (46 anos)
Ms. Vera Bakker Chief Operating Officer 8.03k 1972 (53 ano)
Karen Berg Global Investor Relations Manager N/A
Mr. Johan Verlinden Head of Legal, Mergers & Acquisitions N/A

Endereço: Belgium, Nazareth, Venecoweg 20A - abrir no Google Maps, abrir mapas Yandex
Site: https://www.fagron.com